Effect of Oral Nutritional Supplementation Combined With Impedance Vectors
NCT05288101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2022-03-18
Summary
The objective of this study was to assess the effect of oral nutritional supplementation (ONS) combined with bioelectrical vector analysis (BIVA) on the nutritional and hydration status and the quality of life (QoL) in hemodialysis (HD) patients. Design and Methods: Thirty-two chronic HD patients were included in a 6-month randomized pilot study. Patients in SUPL group received a simultaneous intervention consisting of a personalized diet, 245 mL/d ONS and dry weight adjustment through BIVA. Patients in CON group received a personalized diet and dry weight adjustment by BIVA. Anthropometrical, biochemical, dietary, QoL, handgrip strength (HGS) and bioimpedance measurements were performed. Malnutrition Inflammation Score (MIS) was applied.
Conditions
- Chronic Kidney Disease Requiring Chronic Dialysis
- Overhydration
- Undernutrition
Interventions
- DIETARY_SUPPLEMENT
-
Proteinex and Enterex DBT Victus Laboratories
The supplement was provided five days per week. Three days a week, the supplement was given at the beginning of the HD session and the patients were instructed to consume it slowly during the next 3 hours. The remaining two days, the supplement was consumed at home and instructed to be consumed between meals. The ONS consisted of one can of polymeric formula (Enterex DBT, Victus Laboratories) and 5.6 g of a protein powder supplement (Proteinex, Victus Laboratories). The final mixture provided 240 kcal, 17 g protein, 8.1 g lipids, 25 g carbohydrates, 4 g dietary fiber, 201 mg sodium, 490 mg calcium, 356 mg phosphorus and 371 mg potassium
- PROCEDURE
-
Dry weight adjustment through BIVA
Those participants with post-dialysis vectors located within the 50 or 75% ellipses, were considered to be in dry weight, so they did not require any fluid removal adjustment. However, participants with vectors outside the 75% ellipse were considered overhydrated or dehydrated and dry weight was adjusted. In these patients, if the vectors fell outside the 75% ellipse but within the 95%, above or below the major axis, the established dry weight was adjusted by 0.5 Kg. If the vectors fell outside the 95% ellipse, the weight was adjusted by 1.0 Kg.
Sponsors & Collaborators
-
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
collaborator OTHER -
Indiana University School of Medicine
collaborator OTHER -
Ball State University
collaborator OTHER -
Universidad Autonoma de Queretaro
lead OTHER
Principal Investigators
-
Ximena Atilano-Carsi, PhD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- Mexico
Study Locations
More Related Trials
-
Effect of Prebiotics and/or Probiotics on Uremic Toxins and Inflammation Markers in Peritoneal Dialysis Patients
NCT03770611 ·Status: UNKNOWN ·Phase: NA
-
Protein Supplementation in Dialysis Patients
NCT00367198 ·Status: TERMINATED ·Phase: PHASE2
-
Protein Supplementation in Dialysis Patients
NCT01855295 ·Status: COMPLETED ·Phase: NA
-
Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients
NCT00244075 ·Status: COMPLETED ·Phase: PHASE2
-
Intradialytic Creatine Supplementation
NCT05148208 ·Status: UNKNOWN ·Phase: NA
-
Low-protein Formula Supplements in Chronic Kidney Disease
NCT05318014 ·Status: COMPLETED ·Phase: NA
-
Effects of Short Term Creatine Supplementation in Hemodialysis Patients
NCT07033611 ·Status: COMPLETED ·Phase: NA
-
Impact of Low Protein Diet Supplemented With Ketoanalogues Supplementation on Uremic Toxins Production
NCT03959228 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Homemade Oral Nutrition Supplements for Patients on Hemodialysis With Protein-energy Wasting
NCT06569732 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients
NCT03077048 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of a Phosphate Modified Diet on Phosphate Balance and Phosphate Metabolism in Predialysis Patients Stage 3-4
NCT02073136 ·Status: COMPLETED ·Phase: NA
-
Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
NCT00179205 ·Status: TERMINATED ·Phase: PHASE2
-
Anabolic Steroids and Exercise in Hemodialysis Patients
NCT00250536 ·Status: COMPLETED ·Phase: NA
-
Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and Function
NCT01890811 ·Status: WITHDRAWN ·Phase: NA
-
Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee
NCT00179153 ·Status: COMPLETED ·Phase: PHASE2
-
Supplemented Low Protein Diet and Progression of CKD
NCT03818568 ·Status: COMPLETED ·Phase: NA
-
Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease
NCT00566670 ·Status: COMPLETED
-
Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney Disease
NCT01161407 ·Status: COMPLETED ·Phase: NA
-
Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease
NCT00364884 ·Status: UNKNOWN ·Phase: PHASE4
-
Development of a 'Phosphate Counting Program'
NCT01643486 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4
NCT00764816 ·Status: COMPLETED ·Phase: NA
-
Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT06786260 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease
NCT04819217 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients
NCT02755961 ·Status: COMPLETED ·Phase: NA
-
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
NCT04046263 ·Status: COMPLETED ·Phase: PHASE4